Literature DB >> 10619761

Antimicrobial resistance of Neisseria meningitidis in the United States, 1997. The Active Bacterial Core Surveillance (ABCs) Team.

N E Rosenstein1, S A Stocker, T Popovic, F C Tenover, B A Perkins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10619761     DOI： 10.1086/313599

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  14 in total

1.  Multidrug-resistant Pathogens: Mechanisms of Resistance and Epidemiology.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-10       Impact factor: 3.725

2.  Sequencing of Neisseria meningitidis penA gene: the key to success in defining penicillin G breakpoints.

Authors:  Luisa Arreaza; Celia Salcedo; Belén Alcalá; María José Uría; Raquel Abad; Rocío Enríquez; Julio A Vázquez
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

Review 3.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

4.  International clone of Neisseria meningitidis serogroup A with tetracycline resistance due to tet(B).

Authors:  Sharon A Crawford; Kristin R Fiebelkorn; Jan E Patterson; James H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

5.  Susceptibility of Neisseria meningitidis to 16 antimicrobial agents and characterization of resistance mechanisms affecting some agents.

Authors:  James H Jorgensen; Sharon A Crawford; Kristin R Fiebelkorn
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

Review 6.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

7.  Pharmacodynamic evaluation of meropenem and cefotaxime for pediatric meningitis: a report from the OPTAMA program.

Authors:  Jennifer M Ellis; Joseph L Kuti; David P Nicolau
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

8.  Mutations in folP associated with elevated sulfonamide MICs for Neisseria meningitidis clinical isolates from five continents.

Authors:  K R Fiebelkorn; S A Crawford; J H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

9.  Multilaboratory evaluation of disk diffusion antimicrobial susceptibility testing of Neisseria meningitidis isolates.

Authors:  James H Jorgensen; Sharon A Crawford; Letitia C Fulcher; Anita Glennen; Susan M Harrington; Jana Swenson; Ruth Lynfield; Patrick R Murray; Fred C Tenover
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

10.  Neisseria meningitidis intermediately resistant to penicillin and causing invasive disease in South Africa in 2001 to 2005.

Authors:  Mignon du Plessis; Anne von Gottberg; Cheryl Cohen; Linda de Gouveia; Keith P Klugman
Journal:  J Clin Microbiol       Date:  2008-07-23       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.